Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion

American Journal of Respiratory Cell and Molecular Biology

Volumn 43, Issue 1, 2010, Pages 109-120

  Potter Perigo, Susan ^a   Johnson, Pamela Y ^a   Evanko, Stephen P ^a   Chan, Christina K ^a   Braun, Kathleen R ^a   Wilkinson, Thomas S ^a   Altman, Leonard C ^b   Wight, Thomas N ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

A disintegrin like and metallopeptidase with thrombospondin type 1 motif; Extracellular matrix; Lung inflammation; Monocytes; Versican

Indexed keywords

HYALURONIC ACID; INTERLEUKIN 1BETA; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA; VERSICAN;

ARTICLE; ASTHMA; CELL ADHESION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG FIBROBLAST; MONOCYTE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL ADHESION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; EXTRACELLULAR MATRIX; HUMANS; HYALURONIC ACID; INFLAMMATION; INTERLEUKIN-1BETA; LUNG; MONOCYTES; POLY C; POLY I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOSPONDINS; VERSICANS;

EID: 77956893098     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0081OC     Document Type: Article

References (53)

1. Katoh S, Matsumoto N, Kawakita K, Tominaga A, Kincade PW, Matsukura S. A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J Clin Invest 2003;111:1563-1570. (Pubitemid 38063289)
2. Kai Y, Yoneyama H, Koyama J, Hamada K, Kimura H, Matsushima K. Treatment with chondroitinase ABC alleviates bleomycin-induced pulmonary fibrosis. Med Mol Morphol 2007;40:128-140. (Pubitemid 47415945)
3. Roberts CR. Versican in the cell biology of pulmonary fibrosis. In: Garg HA, Roughly PJ, Hales CN, editors. Proteoglycans in lung disease (lung biology in health and disease). New York: Marcel Dekker; 2002. pp. 191-212.
4. Bensadoun ES, Burke AK, Hogg JC, Roberts CR. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 1996; 154:1819-1828.
5. Merrilees MJ, Hankin EJ, Black JL, Beaumont B. Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis. J Pathol 2004;203:653-660. (Pubitemid 38714102)
6. Merrilees MJ, Ching PS, Beaumont B, Hinek A, Wight TN, Black PN. Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease. Respir Res 2008;9:41.
7. Roberts CR. Is asthma a fibrotic disease? Chest 1995;107:111S-117S.
8. Wilkinson T, Chi E, HendersonW, Lara S, Potter-Perigo S, Merillees M, Altman L, Wight T. Alterations in the lung distribution of hyaluronan and versican in a murine model of asthma [abstract]. J Allergy Clin Immunol 2004;113:S188.
9. de La Motte CA, Hascall VC, Drazba JA, Strong SA. Poly I:C induces mononuclear leukocyte-adhesive hyaluronan structures on colon smooth muscle cells: I alpha I and versican facilitate adhesion. In: Kennedy JF, Phillips GP, Williams PA, Hascall VC, editors. Hyaluronan: chemical, biochemical and biological aspects. Cambridge: Woodhead Publishing Ltd.; 2002. pp. 381-400.
10. Lemanske RF. Viral infections and asthma inception. J Allergy Clin Immunol 2004;114:1023-1026.
11. Lemanske RF Jr, Busse WW. 6. Asthma: factors underlying inception, exacerbation, and disease progression. J Allergy Clin Immunol 2006;117:S456-S461.
12. Groskreutz DJ, Monick MM, Powers LS, Yarovinsky TO, Look DC, Hunninghake GW. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. J Immunol 2006;176:1733-1740.
13. de La Motte CA, Hascall VC, Calabro A, Yen-Lieberman B, Strong SA. Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C). J Biol Chem 1999;274:30747-30755. (Pubitemid 129576819)
14. Day AJ, de la Motte CA. Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol 2005;26:637-643.
15. Bielefeldt-Ohmann H. Role of ctyokines in the pathogenesis and treatment of respiratory disease. In: Myers MJ, Murtaugh MP, editors. Cytokines in animal health and disease. New York: Marcel Dekker; 1995. pp. 291-332.
16. Wilkinson TS, Potter-Perigo S, Tsoi C, Altman LC, Wight TN. Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. Am J Respir Cell Mol Biol 2004;31:92-99. (Pubitemid 38888044)
17. Lemire JM, Chan CK, Bressler S, Miller J, LeBaron RG, Wight TN. Interleukin-1βeta selectively decreases the synthesis of versican by arterial smooth muscle cells. J Cell Biochem 2007;101:753-766. (Pubitemid 46698859)
18. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006;85:699-715.
19. Hascall VC, Majors AK, De La Motte CA, Evanko SP, Wang A, Drazba JA, Strong SA, Wight TN. Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta 1673;2004:3-12.
20. Heldin P, Karousou E, Bernert B, Porsch H, Nishitsuka K, Skandalis SS. Importance of hyaluronan-CD44 interactions in inflammation and tumorigenesis. Connect Tissue Res 2008;49:215-218.
21. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002;14:617-623.
22. Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS metalloproteinases. Biochem J 2005;386:15-27.
23. Stern R. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 2003;13:105R-115R.
24. Harada H, Takahashi M. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem 2007;282:5597-5607. (Pubitemid 47093756)
25. Raghu G, Chen YY, Rusch V, Rabinovitch PS. Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. Am Rev Respir Dis 1988;138:703-708.
26. Underhill CB, Nguyen HA, Shizari M, Culty M. CD44 positive macrophages take up hyaluronan during lung development. Dev Biol 1993;155:324-336. (Pubitemid 23075993)
27. Wilkinson TS, Bressler SL, Evanko SP, Braun KR, Wight TN. Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion. J Cell Physiol 2006;206:378-385.
28. Bernstein EF, Fisher LW, Li K, LeBaron RG, Tan EM, Uitto J. Differential expression of the versican and decorin genes in photo-aged and sun-protected skin: comparison by immunohistochemical and Northern analyses. Lab Invest 1995;72:662-669.
29. Lin W, Shuster S, Maibach HI, Stern R. Patterns of hyaluronan staining are modified by fixation techniques. J Histochem Cytochem 1997;45:1157-1163. (Pubitemid 27347345)
30. Clarris BJ, Fraser JR. On the pericellular zone of some mammalian cells in vitro. Exp Cell Res 1968;49:181-193.
31. Dours-Zimmermann MT, Zimmerman DR. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J Biol Chem 1994;269:32992-32998.
32. Yao LY, Moody C, Schönherr E, Wight TN, Sandell LJ. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol 1994;14:213-225.
33. McGuire PG, Castellot JJ Jr, Orkin RW. Size-dependent hyaluronate degradation by cultured cells. J Cell Physiol 1987;133:267-276.
34. Evanko SP, Johnson PY, Braun KR, Underhill CB, Dudhia J, Wight TN. Platelet-derived growth factor stimulates the formation of versican- hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys 2001;394:29-38.
35. Wight TN. Hyaluronan in atherosclerosis and restenosis [Internet]. Glycoforum; 1998 [updated 1999 Feb 15; accessed August 5, 2009]. Available from: http://www.glycoforum.gr.jp/science/hyaluronan/HA09/HA09E.html
36. Wight TN, Merrilees MJ. Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ Res 2004;94:1158-1167.
37. Tortorella MD, Arner EC, Hills R, Gormley J, Fok K, Pegg L, Munie G, Malfait AM. ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms. Arch Biochem Biophys 2005;444:34-44.
38. Hamel MG, Ajmo JM, Leonardo CC, Zuo F, Sandy JD, Gottschall PE. Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extension. Exp Neurol 2008;210:428-440.
39. Kenagy RD, Plaas AH, Wight TN. Versican degradation and vascular disease. Trends Cardiovasc Med 2006;16:209-215.
40. Gouëffic Y, Potter-Perigo S, Chan CK, Johnson PY, Braun K, Evanko SP, Wight TN. Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM. Atherosclerosis 2007;195:23-30.
41. Lauer ME, Mukhopadhyay D, Fulop C, de la Motte CA, Majors AK, Hascall VC. Primary murine airway smooth muscle cells exposed to poly(I:C) or tunicamycin synthesize a leukocyte-adhesive hyaluronan matrix. J Biol Chem 2009;284:5299-5312.
42. Udabage L, Brownlee GR, Stern R, Brown TJ. Inhibition of hyaluronan degradation by dextran sulphate facilitates characterisation of hyaluronan synthesis: an in vitro and in vivo study. Glycoconj J 2004;20:461-471.
43. Mio K, Stern R. Inhibitors of the hyaluronidases. Matrix Biol 2002;21:31-37.
44. Kuznetsova SA, Issa P, Perruccio EM, Zeng B, Sipes JM, Ward Y, Seyfried NT, Fielder HL, Day AJ, Wight TN, et al. Versican-thrombospondin-1 binding in vitro and colocalization in microfibrils induced by inflammation on vascular smooth muscle cells. J Cell Sci 2006;119:4499-4509.
45. Zheng PS, Vais D, Lapierre D, Liang YY, Lee V, Yang BL, Yang BB. PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. J Cell Sci 2004;117:5887-5895.
46. Selbi W, de la Motte C, Hascall V, Phillips A. BMP-7 modulates hyaluronan-mediated proximal tubular cell-monocyte interaction. J Am Soc Nephrol 2004;15:1199-1211.
47. Wight TN, Kinsella MG, Qwarnström EE. The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol 1992;4:793-801.
48. Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, Wu Y, Kerbel RS, Yang BB. Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 2004;18:754-756.
49. Wu YJ, La Pierre DP, Wu J, Yee AJ, Yang BB. The interaction of versican with its binding partners. Cell Res 2005;15:483-494.
50. Evanko SP, Tammi MI, Tammi RH, Wight TN. Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev 2007;59:1351-1365.
51. Toeda K, Nakamura K, Hirohata S, Hatipoglu OF, Demircan K, Yamawaki H, Ogawa H, Kusachi S, Shiratori Y, Ninomiya Y. Versican is induced in infiltrating monocytes in myocardial infarction. Mol Cell Biochem 2005;280:47-56.
52. McCoy CE, Carpenter S, Palsson-McDermott EM, Gearing LJ, O'Neill LA. Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation. J Biol Chem 2008;283:14277-14285.
53. Perigo S, Braun K, Chan C, Johnson P, Altman L, Wight T. Hyaluronan turnover in the extracellular matrix (ECM) is reduced in human lung fibroblasts (HLF) treated with the viral mimetic, poly I:C. J Allergy Clin Immunol 2008;121:S200.